Director/PDMR Shareholding

RNS Number : 9284A

GlaxoSmithKline PLC

01 October 2015

 

                 GlaxoSmithKline plc

Notification of Transactions of Directors, Persons Discharging Managerial Responsibilities or Connected Persons

I give below details of changes in the Directors' interests in the Ordinary Shares and American Depositary Shares ('ADSs') of GlaxoSmithKline plc (the 'Company').

On 30 September 2015, the Company's Non-Executive Directors were allocated notional Ordinary Shares at a price of £12.51 per Ordinary Share, and notional ADSs at a price of $37.86 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 July 2015 to 30 September 2015:

Non Executive Director	Ordinary Shares	No. of ADSs
Sir Philip Hampton	3,497.202
Professor Sir Roy Anderson	574.540
Dr Stephanie Burns		757.793
Stacey Cartwright	424.660
Lynn  Elsenhans		1,552.170
Judy Lewent		587.943
Sir Deryck Maughan		1,829.157
Dr Daniel Podolsky		1,371.868
Urs Rohner	524.580
Hans Wijers	424.660

The Company and the Non-Executive Directors were informed of these allocations on 1 October 2015.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

1 October 2015

 

END

 

 

RDSFFLFBEBFBFBE